The application of artificial intelligence in the field of brain science has broad prospects, especially in the study of spiritual brain, elderly brain and children's brain, which can provide better methods and strategies.
In order to explore the application of artificial intelligence in the field of cognitive behavior, the Tianqiao Brain Research Institute (TCCI), founded by investor Chen Tianqiao, announced on July 26 that it will cooperate with the Shanghai Mental Health Center to build an artificial intelligence and mental health laboratory, focusing on how to use the in-depth research and transformation of artificial intelligence in the field of mental health and mental health, and carry out mental illness assessment and intervention for the big data established for individual behavior and symptoms.
As part of the first phase of supporting China's brain science of 500 million yuan, TCCI will invest 50 million yuan to jointly build this cutting-edge laboratory with the Shanghai Mental Health Center, and will carry out research and promotion in artificial intelligence technology research, precision medicine development and clinical application transformation in the future.
This is the second large-scale investment project established by TCCI in China after the inauguration and commissioning of TCCI's first frontier laboratory for brain science in Shanghai Huashan Hospital in October last year to further support brain science research.
Professor Xu Yifeng, president of the Shanghai Mental Health Center, said in an exclusive interview with the first financial reporter: "This investment will be used to include the establishment of a large database of brain imaging, as well as research on digital drugs, etc. In the future, cooperation hopes to accelerate the transformation of the results of scientific research projects that have been carried out." ”
Chen Tianqiao believes that although the research on mental illness has a long way to go, this does not mean that people are powerless in the short term. "Artificial intelligence provides a good solution to the problem of using new technologies to carry out objective, long-term, large population research on mental illness, computer modeling, and the development and formation of systematic tools and methods, which will lay the foundation for mental illness research, precision medicine and even innovative digital drug research and development." Chen Tianqiao said via video at the signing ceremony.
In recent years, TCCI has worked with hospitals including Huashan Hospital and Shanghai Mental Health Center, as well as game companies such as Tencent and Sheng Qu to develop digital drug therapies related to the treatment of mental illness, trying to use them for the treatment of psychiatric disorders such as depression, anxiety, and addiction.
However, so far, no digital drug in China has been approved by the drug regulatory authorities, while the US FDA has approved the listing of related digital products.
In this regard, Xu Yifeng told the first financial reporter: "China's drug regulatory authorities also pay great attention to the approval of digital drugs, but products driven by software and algorithms still need to strengthen research in terms of responsibility determination in terms of efficacy or adverse reactions." ”
He also said that the standardization of products in the artificial intelligence industry also needs to be unified. "There is no unified industry standard in China for the time being, so after the establishment of the Artificial Intelligence and Mental Health Laboratory, in addition to launching specific products in the future, we also hope to promote the work of ethics and the establishment of industry standards."
Xu Yifeng also emphasized the issue of data privacy protection. "How to ensure the security of data in the process of collection and use is also something to consider. That is, how to explore more dimensions of information in the brain under the premise of protecting privacy. He told the first financial reporter.
At present, the Shanghai Mental Health Center has launched a multi-center clinical trial of psychotherapy assisted by voice intelligent robots, which has been carried out in many hospitals across the country, and plans to enroll more than 700 patients with anxiety disorders. Xu Yifeng revealed to the first financial reporter that the current clinical trial has enrolled more than 50 patients and is expected to be completed by the end of next year.
He also said that after interventions for people with mental illness, future digital drugs will also help promote mental health in the general population. "The Shanghai Mental Health Center has planned to work with the Shanghai Municipal Education Commission to focus on some surveys on the mental health of primary and secondary school students, as well as training for teachers and parents." If there are parts of such projects related to digital technology and healthcare, TCCI can also participate. Xu Yifeng told the first financial reporter.
![The brain business of internet gangsters: Wang Xiaochuan has entered the game, chen Tianqiao smashed into the "retirement and return to work" of 1 billion Internet gangsters who still have zero output, how wild is the life science under the blessing of the big guys? Life sciences are hard to do[fig]](data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACwAAAAAAQABAAACAkQBADs=)